IRIS Accounts Production v26.2.0.496 08616160 director 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086161602025-03-31086161602026-03-31086161602025-04-012026-03-31086161602024-07-31086161602024-08-012025-03-31086161602025-03-3108616160ns15:EnglandWales2025-04-012026-03-3108616160ns14:PoundSterling2025-04-012026-03-3108616160ns10:Director12025-04-012026-03-3108616160ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3108616160ns10:SmallEntities2025-04-012026-03-3108616160ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3108616160ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3108616160ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3108616160ns10:FullAccounts2025-04-012026-03-3108616160ns10:OrdinaryShareClass12025-04-012026-03-3108616160ns10:RegisteredOffice2025-04-012026-03-3108616160ns5:CurrentFinancialInstruments2026-03-3108616160ns5:CurrentFinancialInstruments2025-03-3108616160ns5:Non-currentFinancialInstruments2026-03-3108616160ns5:Non-currentFinancialInstruments2025-03-3108616160ns5:ShareCapital2026-03-3108616160ns5:ShareCapital2025-03-3108616160ns5:RetainedEarningsAccumulatedLosses2026-03-3108616160ns5:RetainedEarningsAccumulatedLosses2025-03-3108616160ns5:PlantMachinery2025-03-3108616160ns5:FurnitureFittings2025-03-3108616160ns5:ComputerEquipment2025-03-3108616160ns5:PlantMachinery2025-04-012026-03-3108616160ns5:FurnitureFittings2025-04-012026-03-3108616160ns5:ComputerEquipment2025-04-012026-03-3108616160ns5:PlantMachinery2026-03-3108616160ns5:FurnitureFittings2026-03-3108616160ns5:ComputerEquipment2026-03-3108616160ns5:PlantMachinery2025-03-3108616160ns5:FurnitureFittings2025-03-3108616160ns5:ComputerEquipment2025-03-3108616160ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3108616160ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108616160ns5:DeferredTaxation2026-03-3108616160ns10:OrdinaryShareClass12026-03-31
REGISTERED NUMBER: 08616160 (England and Wales)








Unaudited Financial Statements

for the Year Ended 31 March 2026

for

Brainstorm Health Limited

Brainstorm Health Limited (Registered number: 08616160)

Contents of the Financial Statements
for the Year Ended 31 March 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Brainstorm Health Limited

Company Information
for the Year Ended 31 March 2026







DIRECTOR: Mrs S L Minasian Chadwick





REGISTERED OFFICE: 27 River Park Drive
Marlow
SL7 1QT





REGISTERED NUMBER: 08616160 (England and Wales)





ACCOUNTANTS: Lane Monnington Welton
Chartered Accountants
Riverside View
Basing Road
Old Basing
Basingstoke
Hampshire
RG24 7AL

Brainstorm Health Limited (Registered number: 08616160)

Balance Sheet
31 March 2026

31.3.26 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 7,509 8,667

CURRENT ASSETS
Debtors 5 89,688 58,965
Cash at bank and in hand 6,076 1,426
95,764 60,391
CREDITORS
Amounts falling due within one year 6 72,312 34,849
NET CURRENT ASSETS 23,452 25,542
TOTAL ASSETS LESS CURRENT
LIABILITIES

30,961

34,209

CREDITORS
Amounts falling due after more than one
year

7

-

(2,001

)

PROVISIONS FOR LIABILITIES 8 (1,699 ) -
NET ASSETS 29,262 32,208

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 29,260 32,206
SHAREHOLDERS' FUNDS 29,262 32,208

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Brainstorm Health Limited (Registered number: 08616160)

Balance Sheet - continued
31 March 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 August 2026 and were signed by:





Mrs S L Minasian Chadwick - Director


Brainstorm Health Limited (Registered number: 08616160)

Notes to the Financial Statements
for the Year Ended 31 March 2026


1. STATUTORY INFORMATION

Brainstorm Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery - 25% reducing balance
Computer equipment - 33% reducing balance
Office equipment - 25% reducing balance

Financial instruments
Debtors and creditors payable/receivable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price, including transaction costs. Subsequently they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Brainstorm Health Limited (Registered number: 08616160)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, adjusted for indexation where applicable.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Impairment
Assets not measured at fair value are reviewed for any indication that an asset may be impaired at each balance sheet date. The directors review the carrying amount of the relevant assets and compare them to their market values and recoverable amounts. Where the carrying amount exceeds this, an impairment loss is recognised in profit or loss, unless the asset is carried at a revalued amount, where the impairment loss is a revaluation decrease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2025 17,169 24,765 - 41,934
Additions - - 1,099 1,099
At 31 March 2026 17,169 24,765 1,099 43,033
DEPRECIATION
At 1 April 2025 15,167 18,100 - 33,267
Charge for year 500 1,666 91 2,257
At 31 March 2026 15,667 19,766 91 35,524
NET BOOK VALUE
At 31 March 2026 1,502 4,999 1,008 7,509
At 31 March 2025 2,002 6,665 - 8,667

Brainstorm Health Limited (Registered number: 08616160)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Trade debtors 444 2,144
Amounts owed by group undertakings 82,956 56,821
Other debtors 6,288 -
89,688 58,965

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Bank loans and overdrafts 2,002 4,001
Trade creditors 522 1,092
Amounts owed to group undertakings 7,051 5,000
Taxation and social security 2,878 10,750
Other creditors 59,859 14,006
72,312 34,849

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.26 31.3.25
£    £   
Bank loans - 2,001

8. PROVISIONS FOR LIABILITIES
31.3.26 31.3.25
£    £   
Deferred tax 1,699 -

Deferred
tax
£   
Accelerated capital allowances 1,699
Balance at 31 March 2026 1,699

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.26 31.3.25
value: £    £   
2 Ordinary shares 1 2 2